Terms ending in 2041
Every in-force patent on Bionomics Limited's record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,139,473 | Substituted-N-Heteroaryl Compounds and Uses Thereof In force · High confidence | Bionomics Limited | In force | High confidence | |
| US 12,090,146 | Substituted-Pyridinyl Compounds and Uses Thereof In force · High confidence | Bionomics Limited | In force | High confidence | |
| US 12,409,140 | Therapeutic Formulations and Uses Thereof In force · High confidence | Bionomics Limited | In force | High confidence | |
| US 12,275,732 | Cyclic compounds as receptor modulating therapeutics and methods and uses thereof In force · High confidence | Bionomics Limited | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.